Is Heron Therapeutics, Inc. overvalued?

Heron Therapeutics, Inc. (HRTX) — key valuation metrics and fundamentals.

No verdict

Price

$0.31

Fair value

—

Current P/E

—

Normal P/E

28.6

Market cap

$59.1M

Dividend yield

0.0%

Return on equity

-244.3%

Sector

Healthcare

Fair value compares HRTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks